Position:Home / News / Industry Information
Detonate Jiangbei | NADD FORUM 2021 Nucleic Acid Drug Development Forum Grand Opening
时间:2021-10-11 16:21:56 文章来源:yh1122银河国际生物
Moderator: Fei Jia, Director of Guangdong Engineering Technology Research Center for Small Nucleic Acid Drug Development
Member of the Party Working Committee of Jiangbei New Area and Deputy Director of the Management Committee Chen Chanmei addressed the conference
“Nanjing Jiangbei New District serves asThe 13th in the country and the only one in Jiangsu ProvinceNational new-district,Is bearerThe innovation source, leading area and important industrial growth pole of the national strategic mission。In recent years, with the rapid development of the new district, the biomedical industry has ushered in the best development opportunities. As one of the important sectors of the industrial layout of the new district’s ‘two cities and one center’, ‘Gene City’The entire industry chain from new drug R&D and production, precision medicine, to high-end medical devices, and professional health management,500% of the industrial scale in 5 yearsGathering more than 1,000 upstream and downstream enterprises,500% of the industrial scale in 5 yearsThe ultra-high-speed growth of the country. existAccelerated deployment in the field of nucleic acid drugs, with companies such as Jimai Biotech, Oro Biotech, and Zhongji Zhiyao initially appearing,In the future, more related companies will accelerate their landings and gradually build a highland of innovation and transformation of biomedicine sources.”
Global progress in research and development of nucleic acid drug and vector delivery technology
Chen Pu, Academician of the Canadian Academy of Engineering, Founder of Natide Bio
The development status of global nucleic acid drugs
Gao Shan, Senior Deputy General Manager of Suzhou Ruibo Biological
Progress of nucleic acid drugs delivered by polypeptide nanoparticles (PNP) in tumor treatment
Lu Yang, Chairman of Suzhou Shengnuo Biotechnology Co., Ltd.
Helping pharmaceutical companies enter the field of RNA drugs-an open one-stop RNA drug R&D platform
Zhang Peizhuo, Chairman of Gemma Gene
Innovative development and investment opportunities of nucleic acid drugs
Zhao Chunlin, founder of Anlong Bio
From coding to nucleic acid drug development: rapid discovery and optimization of nucleic acid sequences and delivery formulations
Wan Jinqiao, Vice President of Chengdu Leading R&D Chemistry Center
Platform technology based on RNA activation and development of small nucleic acid drugs
Li Longcheng, Chairman of Sino-American Ruikang
Application development of anti-osteosarcoma of national class I new drug miRNA-21 antisense oligonucleotide (ADS-21)
Fei Jia, Director of Guangdong Engineering Technology Research Center for Small Nucleic Acid Drug Development
Research and development of new nucleic acid drug carriers
Yang Zhenjun, Professor, School of Pharmacy, Peking University Health Science Center
Research on Key Technologies of In vivo Delivery of Small Nucleic Acids
Chen Xi, Professor, Department of Biochemistry and Molecular Dean, School of Life Sciences, Nanjing University
Nucleic acid drug delivery strategy
Zhao Lixiang, Professor and Doctoral Supervisor, School of Basic Medicine and Biological Sciences, School of Medicine, Soochow University
Antibody-directed small RNA drugs to treat tumors and cognitive impairment
Zhang Hao, Professor of Jinan University School of Medicine, Director of the Institute of Tumor Precision Medicine and Pathology
Roundtable forum: The drug-readiness and indication expansion of small nucleic acid drugs
Zhang Yi, host, partner in charge of Huagai Medical Yangtze River Delta Fund
Chen Pu, Founder of Natide Biotech, Academician of Canadian Academy of Engineering
Liang Zicai, CEO of Ruibo Biotech
Zhang Peizhuo, Chairman of Gemma Gene
Lu Yang, Chairman of Suzhou Shengnuo Biotechnology Co., Ltd.
Zhang Biliang, Chairman of Ruibo Biological
Li Longcheng, Chairman of Sino-American Ruikang
*The conference will last for two days, May 7-8, interested friends can go to the site to participate, address: Nanjing Jiangbei New District Binjiang Avenue 504, Nanjing Hualuxe Yangtze River Boat. For more event agenda, please check "Read the original text".
-
Suzhou Huiyi bi···
2022/07/19
-
Suzhou huiliao ···
2022/07/19